Search for "vaccine hesitancy"

Filter search results

    No Filter Selected

  • Covid-19 (56)
  • Drug Manufacturers (19)
  • Impact of Chinas Zero COVID lockdowns (17)
  • Covid-19 Executive Briefing (13)
  • Therapy Area (13)
  • Infectious Disease (12)
  • Clinical Trials (8)
  • Regulation (8)
  • Technology (8)
  • Healthcare (3)
  • Respiratory (3)
  • Agilent WP (2)
  • Cerba Research WP (2)
  • Oncology (2)
  • Supply Chain (2)
  • A Program To Accelerate Sales (1)
  • Approvals (1)
  • Biopharmaceutical Industry (1)
  • Cancer (1)
  • Central Nervous System (1)

    No Filter Selected

  • News Analysis and Comments (95)

    No Filter Selected

  • United States of America (11)
  • Global (9)
  • Europe (6)
  • United Kingdom (5)
  • North America (2)
  • Australia (1)
  • Denmark (1)
  • Middle East and Africa (1)
  • Singapore (1)
Showing 20 results out of 95
Uncategorised

How the anti-vax movement became a tech problem

According to the World Health Organisation, in 2018 there was a 30% increase in the number of reported measles cases worldwide. The organisation also recently named “vaccine hesitancy” as one of the top global threats of 2019.

Comment

Unprecedented global demand for Gardasil 9

The widening commercial frontier for Gardasil 9 is a reflection of evolving vaccination objectives across the globe and presents an opportunity to decrease or potentially eliminate HPV-related cancers worldwide

Features

Intellectual property in the time of Covid-19

Governments have been waiving common Intellectual Property laws in pursuit of a treatment for Covid-19, overriding patent protections and allowing sales of generic drugs. This is a concerning move for pharma companies struggling to navigate unclear rules, but could it change the R&D landscape forever? Abi Millar fins out more about IP during the Covid-19 crisis.